Nkarta, Inc. Common Stock

NKTX US65487U1088

💰
Capitalization
Small-cap

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

🔗
Website
https://www.nkartatx.com
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
24
🙍
Insiders
7
Person Price Shares Total Published Completed
Hastings Paul J
CEO 		1.79
USD 		1,790
Sold 		3,204
USD 		18/06/2025 18/06/2025
Hastings Paul J
CEO 		1.79
USD 		1,790
Sold 		3,204
USD 		18/06/2025 18/06/2025
Brandenberger Ralph
CTO 		2.20
USD 		7,447
Sold 		16,383
USD 		15/01/2025 15/01/2025
Hastings Paul J
CEO 		2.20
USD 		17,378
Sold 		38,232
USD 		15/01/2025 15/01/2025
Shook David
O 		2.20
USD 		8,638
Sold 		19,004
USD 		15/01/2025 15/01/2025
Hager Alicia J.
CLO 		2.20
USD 		9,584
Sold 		21,085
USD 		15/01/2025 15/01/2025
Levin Alyssa
O 		2.20
USD 		5,838
Sold 		12,844
USD 		15/01/2025 15/01/2025
Hager Alicia J.
CLO 		8.00
USD 		3,396
Sold 		27,168
USD 		16/07/2024 16/07/2024
Hastings Paul J
CEO 		5.60
USD 		1,770
Sold 		9,912
USD 		18/06/2024 18/06/2024
Trager James
CSO 		5.60
USD 		456
Sold 		2,554
USD 		18/06/2024 18/06/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Nkarta, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
George Simeon 2 20,000,000.00 10,000,000.00 27/03/2024 27/03/2024
Hastings Paul J 7 2,134,725.44 304,960.78 16/01/2024 18/06/2025
Brandenberger Ralph 4 144,291.85 36,072.96 16/01/2024 15/01/2025
Hager Alicia J. 4 92,125.96 23,031.49 16/01/2024 15/01/2025
Trager James 3 92,124.00 30,708.00 16/01/2024 18/06/2024
Shook David 3 52,601.68 17,533.89 16/01/2024 15/01/2025
Levin Alyssa 1 12,843.60 12,843.60 15/01/2025 15/01/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.